These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6896209)
1. Heterogeneity of the natural humoral anti-tumor immune response in mice as shown by monoclonal antibodies. Colnaghi MI; Menard S; Tagliabue E; Torre GD J Immunol; 1982 Jun; 128(6):2757-62. PubMed ID: 6896209 [TBL] [Abstract][Full Text] [Related]
2. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
3. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity. Prager MD; Granatek CH; Ludden CM Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines. Fuji H Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline. Testorelli C; Archetti YL; Aresca P; Del Vecchio L Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006 [TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Seto M; Takahashi T; Nakamura S; Matsudaira Y; Nishizuka Y Cancer Res; 1983 Oct; 43(10):4768-73. PubMed ID: 6192909 [TBL] [Abstract][Full Text] [Related]
8. The in vitro antibody response to cell surface antigens. II. Monoclonal antibodies to human leukemia cells. Levy R; Dilley J J Immunol; 1977 Aug; 119(2):394-400. PubMed ID: 301891 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. Ozato K; Hansen TH; Sachs DH J Immunol; 1980 Dec; 125(6):2473-7. PubMed ID: 7191868 [TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies that define rat T cell alloantigens. Ely JM; Greiner DL; Lubaroff DM; Fitch FW J Immunol; 1983 Jun; 130(6):2798-803. PubMed ID: 6343484 [TBL] [Abstract][Full Text] [Related]
12. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
13. Defining the heterogeneity of anti-tumor antibody responses. Segal GP; Klinman NR J Immunol; 1976 Jun; 116(6):1539-46. PubMed ID: 58038 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. Ozato K; Sachs DH J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen. Li G; Hu J; Zhou G; Zhu J; Sun Q Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro production and detection of monoclonal antibodies to surface components on metastatic variants of murine tumor cells. Miner KM; Reading CL; Nicolson GL Invasion Metastasis; 1981; 1(3):158-74. PubMed ID: 6897920 [TBL] [Abstract][Full Text] [Related]
17. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Tremblay N; Fontaine P; Perreault C Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709 [TBL] [Abstract][Full Text] [Related]
19. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319 [TBL] [Abstract][Full Text] [Related]
20. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells. Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]